Doseresponse effects on HbA(1c) and bodyweight reduction of survodutide, a dual glucagon/GLP- 1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
Authors' contributions OB developed the structural design of the review, coordinated the work and did together with SJ the major part of drafting of the manuscript
This is the workhorse
J Matern Fetal Neonatal Med 33(1):96102 Skalnaya MG, Tinkov AA, Lobanova YN, Chang JS, Skalny AV (2019) Serum levels of copper, iron, and manganese in women with pregnancy, miscarriage, and primary infertility
The current clinical evidence of intravenous glutathione for skin lightening is limited to a single study with a dubious study design and apparently flawed analysis of results, casting doubt on the drug's efficacy and reported adverse effects, with no evidence to prove its efficacy.There was only one placebo-controlled study on intravenous glutathione showing 37.5% response versus 18.7% placebo, and IV glutathione is contraindicated due to lack of efficacy and side effects
Toxicol Sci 91 , 365371, doi: 10.1093/toxsci/kfj165 (2006)